EIRGEN PHARMA LTD.

ALPHAREN

Pharmaceutical [ and veterinary ] preparations for the treatment of musculoskeletal, renal, endocrinal, and neurological diseases; Pharmaceutical preparations, namely, phosphate binders for use in the treatment of hyperphosphataemia; Magnesium iron hydroxy carbonate and hydrotalcite for medical, pharmaceutical [ and veterinary ] preparations for use in renal dialysis and in the treatment of renal diseases and kidney ailments; pharmaceutical [ and veterinary ] preparations for use in treating bone, muscle and kidney diseases and disorders; pharmaceutical [ and veterinary ] preparations for controlling phosphorous metabolism and calcium metabolism;

RAYALDEE

pharmaceutical preparations for the treatment of diseases and disorders of the parathyroid and renal disease; pharmaceutical preparations for the treatment of hyperparathyroidism; pharmaceuticals for the treatment of secondary hyperparathyroidism; pharmaceutical preparations for the treatment of vitamin D deficiency; nutritional supplements, vitamin supplements;

RESCUE

prescription pharmaceutical products, namely, calcifediol for treating symptoms from infection with the SARS-CoV-2 virus (COVID-19);

STOP KIDNEYING AROUND

STOP KIDDING AROUND;Medical information; Providing medical information; Providing medical information to health care providers in the form of reports in the field of chronic kidney disease;